GAITHERSBURG, Md. (AP) _ Novavax Inc. (NVAX) on Monday reported a loss of $49.3 million in its fourth quarter.
The Gaithersburg, Maryland-based company said it had a loss of 13 cents per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.
The vaccine maker posted revenue of $6.1 million in the period, which also did not meet Street forecasts. Five analysts surveyed by Zacks expected $7.9 million.
For the year, the company reported that its loss widened to $184.7 million, or 50 cents per share. Revenue was reported as $34.3 million.
In the final minutes of trading on Monday, the company's shares hit 52 cents. A year ago, they were trading at $2.16.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVAX at https://www.zacks.com/ap/NVAX